Enhancing hepatitis C treatment uptake and outcomes for injection drug users.
Dore
Gregory J
GJ
D000998:Antiviral Agents / Q000627:therapeutic use; D006526:Hepatitis C / Q000188:drug therapy* / Q000635:transmission; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D009271:Naltrexone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use; D010349:Patient Compliance; D012254:Ribavirin / Q000627:therapeutic use; D015819:Substance Abuse, Intravenous / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome
D000998:Antiviral Agents; D009292:Narcotic Antagonists; D012254:Ribavirin; D009271:Naltrexone; D007372:Interferons